Referenser

Acosta, S., Frykholm, P., Granath, A., Hammarskjold, F., Lindgren, S., Lindwall, R., Åkeson, J. SFAI:s riktlinjer för centrala venkatetrar. Retrieved from https://sfai.se/riktlinje/medicinska-rad-och-riktlinjer/anestesi/cvk/

Alderuccio, J. P., & Lossos, I. S. (2018). DA-EPOCH-R for Adult Burkitt's Lymphoma: Pros and Cons. J Oncol Pract, 14(11), 676-678. doi:10.1200/jop.18.00624

Alibhai, S. M., O'Neill, S., Fisher-Schlombs, K., Breunis, H., Brandwein, J. M., Timilshina, N., Culos-Reed, S. N. (2012). A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy. Leuk Res, 36(10), 1255-1261. doi:10.1016/j.leukres.2012.05.016

Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Preiser, J.-C. (2017). ESPEN guidelines on nutrition in cancer patients. Clinical Nutrition, 36(1), 11-48. doi:https://doi.org/10.1016/j.clnu.2016.07.015

Bachanova, V., Marks, D. I., Zhang, M. J., Wang, H., de Lima, M., Aljurf, M. D., Weisdorf, D. J. (2014). Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual disease. Leukemia, 28(3), 658-665. doi:10.1038/leu.2013.253

Becker, S., Vermeulin, T., Cottereau, A. S., Boissel, N., Vera, P., & Lepretre, S. (2017). Predictive value of (18)F-FDG PET/CT in adults with T-cell lymphoblastic lymphoma: post hoc analysis of results from the GRAALL-LYSA LLO3 trial. Eur J Nucl Med Mol Imaging, 44(12), 2034-2041. doi:10.1007/s00259-017-3776-3

Bergfelt, E., Kozlowski, P., Ahlberg, L., Hulegardh, E., Hagglund, H., Karlsson, K., Hallbook, H. (2015). Satisfactory outcome after intensive chemotherapy with pragmatic use of minimal residual disease (MRD) monitoring in older patients with Philadelphia-negative B cell precursor acute lymphoblastic leukaemia: a Swedish registry-based study. Med Oncol, 32(4), 135. doi:10.1007/s12032-015-0582-2

Boissel, N., & Sender, L. S. (2015). Best Practices in Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia: A Focus on Asparaginase. J Adolesc Young Adult Oncol, 4(3), 118-128. doi:10.1089/jayao.2015.0014

Bozzetti, F., Arends, J., Lundholm, K., Micklewright, A., Zurcher, G., & Muscaritoli, M. (2009). ESPEN Guidelines on Parenteral Nutrition: non-surgical oncology. Clin Nutr, 28(4), 445-454. doi:10.1016/j.clnu.2009.04.011

Brissot, E., Labopin, M., Beckers, M. M., Socie, G., Rambaldi, A., Volin, L., Mohty, M. (2015). Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia. Haematologica, 100(3), 392-399. doi:10.3324/haematol.2014.116954

Bruserud, O., Reikvam, H., Kittang, A. O., Ahmed, A. B., Tvedt, T. H., Sjo, M., & Hatfield, K. J. (2012). High-dose etoposide in allogeneic stem cell transplantation. Cancer Chemother Pharmacol, 70(6), 765-782. doi:10.1007/s00280-012-1990-z

Cairo, M. S., Coiffier, B., Reiter, A., Younes, A., & Panel, T. L. S. E. (2010). Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus. Br J Haematol, 149(4), 578-586. doi:10.1111/j.1365-2141.2010.08143.x

Candoni, A., Rambaldi, A., Fanin, R., Velardi, A., Arcese, W., Ciceri, F., Bonifazi, F. (2019). Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors: A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (GITMO). Biol Blood Marrow Transplant, 25(12), 2388-2397. doi:10.1016/j.bbmt.2019.07.037

Chalandon, Y., Thomas, X., Hayette, S., Cayuela, J. M., Abbal, C., Huguet, F., Group for Research on Adult Acute Lymphoblastic, L. (2015). Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia. Blood, 125(24), 3711-3719. doi:10.1182/blood-2015-02-627935

Chang, P. H., Lai, Y. H., Shun, S. C., Lin, L. Y., Chen, M. L., Yang, Y., Cheng, S. Y. (2008). Effects of a walking intervention on fatigue-related experiences of hospitalized acute myelogenous leukemia patients undergoing chemotherapy: a randomized controlled trial. J Pain Symptom Manage, 35(5), 524-534. doi:10.1016/j.jpainsymman.2007.06.013

Cheson, B. D., Pfistner, B., Juweid, M. E., Gascoyne, R. D., Specht, L., Horning, S. J., Diehl, V. (2007). Revised response criteria for malignant lymphoma. J Clin Oncol, 25(5), 579-586. doi:10.1200/jco.2006.09.2403

Churchman, M. L., Qian, M., Te Kronnie, G., Zhang, R., Yang, W., Zhang, H., Mullighan, C. G. (2018). Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia. Cancer Cell, 33(5), 937-948 e938. doi:10.1016/j.ccell.2018.03.021

Cortelazzo, S., Intermesoli, T., Oldani, E., Ciceri, F., Rossi, G., Pogliani, E. M., Bassan, R. (2012). Results of a lymphoblastic leukemia-like chemotherapy program with risk-adapted mediastinal irradiation and stem cell transplantation for adult patients with lymphoblastic lymphoma. Ann Hematol, 91(1), 73-82. doi:10.1007/s00277-011-1252-x

Czyz, A., Labopin, M., Giebel, S., Socie, G., Apperley, J., Volin, L., Nagler, A. (2018). Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation. Am J Hematol, 93(6), 778-785. doi:10.1002/ajh.25091

Dabaja, B. S., Ha, C. S., Thomas, D. A., Wilder, R. B., Gopal, R., Cortes, J., Kantarjian, H. M. (2002). The role of local radiation therapy for mediastinal disease in adults with T-cell lymphoblastic lymphoma. Cancer, 94(10), 2738-2744. doi:10.1002/cncr.10552

DeAngelo, D. J., Stevenson, K. E., Dahlberg, S. E., Silverman, L. B., Couban, S., Supko, J. G., Stone, R. M. (2015). Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia. Leukemia, 29(3), 526-534. doi:10.1038/leu.2014.229

Dunleavy, K., Pittaluga, S., Shovlin, M., Steinberg, S. M., Cole, D., Grant, C., Wilson, W. H. (2013). Low-intensity therapy in adults with Burkitt's lymphoma. N Engl J Med, 369(20), 1915-1925. doi:10.1056/NEJMoa1308392

Ek, T., & Nilsson, A. Vaccinationer efter lågintensiv cytostatikabehandling. Retrieved from http://www.blf.net/onko/page16/files/VaccinationsPM%2020140509.pdf

Elad, S., Raber-Durlacher, J. E., Brennan, M. T., Saunders, D. P., Mank, A. P., Zadik, Y., Jensen, S. B. (2015). Basic oral care for hematology-oncology patients and hematopoietic stem cell transplantation recipients: a position paper from the joint task force of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) and the European Society for Blood and Marrow Transplantation (EBMT). Support Care Cancer, 23(1), 223-236. doi:10.1007/s00520-014-2378-x

Ellin, F., Jerkeman, M., Hagberg, H., & Relander, T. (2014). Treatment outcome in T-cell lymphoblastic lymphoma in adults - a population-based study from the Swedish Lymphoma Registry. Acta Oncol, 53(7), 927-934. doi:10.3109/0284186x.2014.889850

Gajjar, A., Harrison, P. L., Sandlund, J. T., Rivera, G. K., Ribeiro, R. C., Rubnitz, J. E., Pui, C. H. (2000). Traumatic lumbar puncture at diagnosis adversely affects outcome in childhood acute lymphoblastic leukemia. Blood, 96(10), 3381-3384. 

Galvano, A., Guarini, A., Iacono, F., Castiglia, M., Rizzo, S., Tarantini, L., Russo, A. (2019). An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting TKI-based therapy. Expert Opinion on Drug Safety, 18(6), 485-496. doi:10.1080/14740338.2019.1613371

Gao, R. W., Dusenbery, K. E., Cao, Q., Smith, A. R., & Yuan, J. (2018). Augmenting Total Body Irradiation with a Cranial Boost before Stem Cell Transplantation Protects Against Post-Transplant Central Nervous System Relapse in Acute Lymphoblastic Leukemia. Biol Blood Marrow Transplant, 24(3), 501-506. doi:10.1016/j.bbmt.2017.11.013

Giebel, S., Labopin, M., Potter, M., Poire, X., Sengeloev, H., Socie, G., Nagler, A. (2018). Comparable results of autologous and allogeneic haematopoietic stem cell transplantation for adults with Philadelphia-positive acute lymphoblastic leukaemia in first complete molecular remission: An analysis by the Acute Leukemia Working Party of the EBMT. Eur J Cancer, 96, 73-81. doi:10.1016/j.ejca.2018.03.018

Giebel, S., Marks, D. I., Boissel, N., Baron, F., Chiaretti, S., Ciceri, F., Dombret, H. (2019). Hematopoietic stem cell transplantation for adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission: a position statement of the European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplant, 54(6), 798-809. doi:10.1038/s41409-018-0373-4

Gokbuget, N., Dombret, H., Bonifacio, M., Reichle, A., Graux, C., Faul, C., Bargou, R. C. (2018). Blinatumomab for minimal residual disease in adults with B-cell precursor acute lymphoblastic leukemia. Blood, 131(14), 1522-1531. doi:10.1182/blood-2017-08-798322

Gokbuget, N., Dombret, H., Giebel, S., Bruggemann, M., Doubek, M., Foa, R., Bassan, R. (2019). Minimal residual disease level predicts outcome in adults with Ph-negative B-precursor acute lymphoblastic leukemia. Hematology, 24(1), 337-348. doi:10.1080/16078454.2019.1567654

Gokbuget, N., Stanze, D., Beck, J., Diedrich, H., Horst, H. A., Huttmann, A., Hoelzer, D. (2012). Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation. Blood, 120(10), 2032-2041. doi:10.1182/blood-2011-12-399287

Greiner, J., Schrappe, M., Claviez, A., Zimmermann, M., Niemeyer, C., Kolb, R., Moricke, A. (2019). THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents. Haematologica, 104(4), 756-765. doi:10.3324/haematol.2018.194175

Hammarskjold, F., Wallen, G., & Malmvall, B. E. (2006). Central venous catheter infections at a county hospital in Sweden: a prospective analysis of colonization, incidence of infection and risk factors. Acta Anaesthesiol Scand, 50(4), 451-460. doi:10.1111/j.1399-6576.2006.00974.x

Hellberg, E., & Nissander, N. (2017). Fysioterapeutiskt vårdprogram för patienter som genomgår cytostatikabehandling på grund av hematologisk malignitet 2017 Retrieved from https://www.fysioterapeuterna.se/Om-forbundet/Sektioner/Onkologi-och-palliativ-medicin/

https://www.fysioterapeuterna.se/globalassets/_sektioner/onkologi-och-palliativ-medicin/intressegrupper/hematologi/fysioterapeutiskt-vardprogram-for-hematologpatienter-under-cytostatikabehandling-2017.pdf

Higgins, A. Y., O'Halloran, T. D., & Chang, J. D. (2015). Chemotherapy-induced cardiomyopathy. Heart Fail Rev, 20(6), 721-730. doi:10.1007/s10741-015-9502-y

Hoelzer, D., Gökbuget, N., Digel, W., Faak, T., Kneba, M., Reutzel, R., Walewski, J. (2002). Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood, 99, 4379-4385. doi:10.1182/blood-2002-01-0110

Hoelzer, D., Walewski, J., Dohner, H., Viardot, A., Hiddemann, W., Spiekermann, K., German Multicenter Study Group for Adult Acute Lymphoblastic, L. (2014). Improved outcome of adult Burkitt lymphoma/leukemia with rituximab and chemotherapy: report of a large prospective multicenter trial. Blood, 124(26), 3870-3879. doi:10.1182/blood-2014-03-563627

Huguet, F., Leguay, T., Raffoux, E., Thomas, X., Beldjord, K., Delabesse, E., Dombret, H. (2009). Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study. J Clin Oncol, 27(6), 911-918. doi:10.1200/jco.2008.18.6916

Hwang, Y. Y., Mohty, M., & Chim, C. S. (2015). Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond. Hematology, 20(2), 61-71. doi:10.1179/1607845414Y.0000000175

Jabbour, E., Short, N. J., Jorgensen, J. L., Yilmaz, M., Ravandi, F., Wang, S. A., Kantarjian, H. (2016). Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Cancer. doi:10.1002/cncr.30264

Jamieson, C. H., Amylon, M. D., Wong, R. M., & Blume, K. G. (2003). Allogeneic hematopoietic cell transplantation for patients with high-risk acute lymphoblastic leukemia in first or second complete remission using fractionated total-body irradiation and high-dose etoposide: a 15-year experience. Exp Hematol, 31(10), 981-986. doi:10.1016/s0301-472x(03)00231-5

Kantarjian, H. M., DeAngelo, D. J., Stelljes, M., Liedtke, M., Stock, W., Gokbuget, N., Advani, A. S. (2019). Inotuzumab ozogamicin versus standard of care in relapsed or refractory acute lymphoblastic leukemia: Final report and long-term survival follow-up from the randomized, phase 3 INO-VATE study. Cancer, 125(14), 2474-2487. doi:10.1002/cncr.32116

Keefe, D. M., Schubert, M. M., Elting, L. S., Sonis, S. T., Epstein, J. B., Raber-Durlacher, J. E., Peterson, D. E. (2007). Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer, 109(5), 820-831. doi:10.1002/cncr.22484

Klaassen, I. L. M., Zuurbier, C. C. M., Hutten, B. A., van den Bos, C., Schouten, A. Y. N., Stokhuijzen, E., & van Ommen, C. H. (2019). Venous Thrombosis in Children with Acute Lymphoblastic Leukemia Treated on DCOG ALL-9 and ALL-10 Protocols: The Effect of Fresh Frozen Plasma. TH Open, 3(2), e109-e116. doi:10.1055/s-0039-1688412

Knips, L., Bergenthal, N., Streckmann, F., Monsef, I., Elter, T., & Skoetz, N. (2019). Aerobic physical exercise for adult patients with haematological malignancies. Cochrane Database Syst Rev, 1, Cd009075. doi:10.1002/14651858.CD009075.pub3

Kozlowski, P., Astrom, M., Ahlberg, L., Bernell, P., Hulegardh, E., Hagglund, H., Hallbook, H. (2012). High curability via intensive reinduction chemotherapy and stem cell transplantation in young adults with relapsed acute lymphoblastic leukemia in Sweden 2003-2007. Haematologica, 97(9), 1414-1421. doi:haematol.2011.057851 [pii] 10.3324/haematol.2011.057851

Kozlowski, P., Lennmyr, E., Ahlberg, L., Bernell, P., Hulegardh, E., Karbach, H., Hallbook, H. (2017). Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden. Eur J Haematol, 99(2), 141-149. doi:10.1111/ejh.12896

Kozlowski, P., Lennmyr, E., Ahlberg, L., Bernell, P., Hulegårdh, E., Karbach, H., Group, t. S. A. A. L. L. (2017). Age but not Philadelphia positivity impairs outcome in older/elderly patients with acute lymphoblastic leukemia in Sweden. 99(2), 141-149. doi:10.1111/ejh.12896

Kratz, C. P., Stanulla, M., & Cavé, H. (2016). Genetic predisposition to acute lymphoblastic leukemia: Overview on behalf of the I-BFM ALL Host Genetic Variation Working Group. European Journal of Medical Genetics, 59(3), 111-115. doi:https://doi.org/10.1016/j.ejmg.2015.10.003

Lennmyr, E., Karlsson, K., Ahlberg, L., Garelius, H., Hulegardh, E., Izarra, A. S., Hallbook, H. (2019). Survival in adult acute lymphoblastic leukaemia (ALL): A report from the Swedish ALL Registry. Eur J Haematol, 103(2), 88-98. doi:10.1111/ejh.13247

Lim, S. N., Joo, Y. D., Lee, K. H., Kim, D. Y., Lee, J. H., Lee, J. H., Jang, D. Y. (2015). Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Am J Hematol, 90(11), 1013-1020. doi:10.1002/ajh.24137

Maertens, J. A., Girmenia, C., Bruggemann, R. J., Duarte, R. F., Kibbler, C. C., Ljungman, P., Cordonnier, C. (2018). European guidelines for primary antifungal prophylaxis in adult haematology patients: summary of the updated recommendations from the European Conference on Infections in Leukaemia. J Antimicrob Chemother, 73(12), 3221-3230. doi:10.1093/jac/dky286

Marks, D. I., Forman, S. J., Blume, K. G., Perez, W. S., Weisdorf, D. J., Keating, A., Horowitz, M. M. (2006). A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transplant, 12(4), 438-453. doi:10.1016/j.bbmt.2005.12.029

Marks, D. I., Wang, T., Perez, W. S., Antin, J. H., Copelan, E., Gale, R. P., Weisdorf, D. J. (2010). The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission. Blood, 116(3), 366-374. doi:blood-2010-01-264077 [pii] 10.1182/blood-2010-01-264077

Maury, S., Chevret, S., Thomas, X., Heim, D., Leguay, T., Huguet, F., for, G. (2016). Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia. N Engl J Med, 375(11), 1044-1053. doi:10.1056/NEJMoa1605085

Mogensen, S. S., Harila-Saari, A., Makitie, O., Myrberg, I. H., Niinimaki, R., Vestli, A., Frandsen, T. L. (2018). Comparing osteonecrosis clinical phenotype, timing, and risk factors in children and young adults treated for acute lymphoblastic leukemia. Pediatr Blood Cancer, 65(10), e27300. doi:10.1002/pbc.27300

Mohty, M., Labopin, M., Volin, L., Gratwohl, A., Socie, G., Esteve, J., Rocha, V. (2010). Reduced-intensity versus conventional myeloablative conditioning allogeneic stem cell transplantation for patients with acute lymphoblastic leukemia: a retrospective study from the European Group for Blood and Marrow Transplantation. Blood, 116(22), 4439-4443. doi:blood-2010-02-266551 [pii] 10.1182/blood-2010-02-266551

Neale, G. A., Coustan-Smith, E., Stow, P., Pan, Q., Chen, X., Pui, C. H., & Campana, D. (2004). Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia, 18(5), 934-938. doi:10.1038/sj.leu.2403348

O'Brien, S. H., Li, D., Mitchell, L. G., Hess, T., Zee, P., Yee, D. L., Rodriguez, V. (2019). PREVAPIX-ALL: Apixaban Compared to Standard of Care for Prevention of Venous Thrombosis in Paediatric Acute Lymphoblastic Leukaemia (ALL)-Rationale and Design. Thromb Haemost, 119(5), 844-853. doi:10.1055/s-0039-1679938

O'Grady, N. P., Alexander, M., Dellinger, E. P., Gerberding, J. L., Heard, S. O., Maki, D. G., Weinstein, R. A. (2002). Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep, 51(Rr-10), 1-29. 

Olsson, C., Sandin-Bojo, A. K., Bjuresater, K., & Larsson, M. (2015). Patients treated for hematologic malignancies: affected sexuality and health-related quality of life. Cancer Nurs, 38(2), 99-110. doi:10.1097/ncc.0000000000000141

Pavlu, J., Labopin, M., Niittyvuopio, R., Socie, G., Yakoub-Agha, I., Wu, D., Mohty, M. (2019). Measurable residual disease at myeloablative allogeneic transplantation in adults with acute lymphoblastic leukemia: a retrospective registry study on 2780 patients from the acute leukemia working party of the EBMT. J Hematol Oncol, 12(1), 108. doi:10.1186/s13045-019-0790-x

Peterson, C. (2005). [Natural remedies--self care at your own risk! Danger of unknown adverse effects and interactions with "common" medications]. Lakartidningen, 102(44), 3200-3201. 

Pfeifer, H., Wassmann, B., Bethge, W., Dengler, J., Bornhauser, M., Stadler, M., Group, G. S. (2013). Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia. Leukemia, 27(6), 1254-1262. doi:10.1038/leu.2012.352

Porkka, K., Koskenvesa, P., Lundan, T., Rimpilainen, J., Mustjoki, S., Smykla, R., Lee, F. Y. (2008). Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome-positive leukemia. Blood, 112(4), 1005-1012. doi:10.1182/blood-2008-02-140665

Qian, M., Cao, X., Devidas, M., Yang, W., Cheng, C., Dai, Y., Yang, J. J. (2018). TP53 Germline Variations Influence the Predisposition and Prognosis of B-Cell Acute Lymphoblastic Leukemia in Children. J Clin Oncol, 36(6), 591-599. doi:10.1200/JCO.2017.75.5215

Quist-Paulsen, P., Toft, N., Heyman, M., Abrahamsson, J., Griskevicius, L., Hallbook, H., Schmiegelow, K. (2019). T-cell acute lymphoblastic leukemia in patients 1-45 years treated with the pediatric NOPHO ALL2008 protocol. Leukemia. doi:10.1038/s41375-019-0598-2

Rank, C. U., Toft, N., Tuckuviene, R., Grell, K., Nielsen, O. J., Frandsen, T. L., Schmiegelow, K. (2018). Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years. Blood, 131(22), 2475-2484. doi:10.1182/blood-2018-01-827949

Roila, F., Molassiotis, A., Herrstedt, J., Aapro, M., Gralla, R. J., Bruera, E., van der Wetering, M. (2016). 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol, 27(suppl 5), v119-v133. doi:10.1093/annonc/mdw270

Rosendahl, M., Andersen, M. T., Ralfkiaer, E., Kjeldsen, L., Andersen, M. K., & Andersen, C. Y. (2010). Evidence of residual disease in cryopreserved ovarian cortex from female patients with leukemia. Fertil Steril, 94(6), 2186-2190. doi:10.1016/j.fertnstert.2009.11.032

Sanchez Varela, V., Zhou, E. S., & Bober, S. L. (2013). Management of sexual problems in cancer patients and survivors. Curr Probl Cancer, 37(6), 319-352. doi:10.1016/j.currproblcancer.2013.10.009

Santoro, N., Ruggeri, A., Labopin, M., Bacigalupo, A., Ciceri, F., Gulbas, Z., Nagler, A. (2017). Unmanipulated haploidentical stem cell transplantation in adults with acute lymphoblastic leukemia: a study on behalf of the Acute Leukemia Working Party of the EBMT. J Hematol Oncol, 10(1), 113. doi:10.1186/s13045-017-0480-5

Sengar, M., Jain, H., Menon, H., Epari, S., Agrawal, A., Rangarajan, V., Laskar, S. (2013). Whole Body PET-CT In Management Of Lymphoblastic Lymphomas In Adults: Does It Have a Prognostic Impact? Blood, 122(21), 4314-4314. doi:10.1182/blood.V122.21.4314.4314 %J Blood

Shem-Tov, N., Peczynski, C., Labopin, M., Itala-Remes, M., Blaise, D., Labussiere-Wallet, H., Nagler, A. (2020). Haploidentical vs. unrelated allogeneic stem cell transplantation for acute lymphoblastic leukemia in first complete remission: on behalf of the ALWP of the EBMT. Leukemia, 34(1), 283-292. doi:10.1038/s41375-019-0544-3

Short, N. J., Jabbour, E., Albitar, M., de Lima, M., Gore, L., Jorgensen, J., Kantarjian, H. (2019). Recommendations for the assessment and management of measurable residual disease in adults with acute lymphoblastic leukemia: A consensus of North American experts. Am J Hematol, 94(2), 257-265. doi:10.1002/ajh.25338

Speziali, C., Paulson, K., & Seftel, M. (2016). Hematopoietic Cell Transplantation for Acute Lymphoblastic Leukemia in Adults. Curr Hematol Malig Rep, 11(3), 175-184. doi:10.1007/s11899-016-0317-2

Spinelli, O., Peruta, B., Tosi, M., Guerini, V., Salvi, A., Zanotti, M. C., Rambaldi, A. (2007). Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia. Haematologica, 92(5), 612-618. 

Swerdlow, S. H. (2017). WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer.

Thomas, D. A., O'Brien, S., Cortes, J., Giles, F. J., Faderl, S., Verstovsek, S., Kantarjian, H. (2004). Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood, 104(6), 1624-1630. doi:10.1182/blood-2003-12-4428

Toft, N., Birgens, H., Abrahamsson, J., Griskevicius, L., Hallbook, H., Heyman, M., Schmiegelow, K. (2018). Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia. Leukemia, 32(3), 606-615. doi:10.1038/leu.2017.265

Toft, N., Birgens, H., Abrahamsson, J., Griskevicius, L., Hallbook, H., Heyman, M., Schmiegelow, K. (2016). Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia. Eur J Haematol, 96(2), 160-169. doi:10.1111/ejh.12562

Uzunel, M., Jaksch, M., Mattsson, J., & Ringden, O. (2003). Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia. Br J Haematol, 122(5), 788-794. doi:4495 [pii]

Wallace, W. H. (2011). Oncofertility and preservation of reproductive capacity in children and young adults. Cancer, 117(10 Suppl), 2301-2310. doi:10.1002/cncr.26045

van Dalen, E. C., Mank, A., Leclercq, E., Mulder, R. L., Davies, M., Kersten, M. J., & van de Wetering, M. D. (2012). Low bacterial diet versus control diet to prevent infection in cancer patients treated with chemotherapy causing episodes of neutropenia. Cochrane Database Syst Rev(9), Cd006247. doi:10.1002/14651858.CD006247.pub2

Wang, L., Wang, J. H., Bi, X. W., Chen, X. Q., Lu, Y., & Xia, Z. J. (2017). Interim PET-CT may predict PFS and OS in T-ALL/LBL adult patients. Oncotarget, 8(58), 99104-99111. doi:10.18632/oncotarget.19572

Warraich, Z., Tenneti, P., Thai, T., Hubben, A., Amin, H., McBride, A., Anwer, F. (2020). Relapse Prevention with Tyrosine Kinase Inhibitors after Allogeneic Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblast Leukemia: A Systematic Review. Biol Blood Marrow Transplant, 26(3), e55-e64. doi:10.1016/j.bbmt.2019.09.022

Vignetti, M., Fazi, P., Cimino, G., Martinelli, G., Di Raimondo, F., Ferrara, F., Mandelli, F. (2007). Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol. Blood, 109(9), 3676-3678. 

Vines, A. N., Shanholtz, C. B., & Thompson, J. L. (2010). Fixed-dose rasburicase 6 mg for hyperuricemia and tumor lysis syndrome in high-risk cancer patients. Ann Pharmacother, 44(10), 1529-1537. doi:10.1345/aph.1P296

Wrzesien-Kus, A., Robak, T., Pluta, A., Zwolinska, M., Wawrzyniak, E., Wierzbowska, A., Palynyczko, G. (2006). Outcome of treatment in adults with Philadelphia chromosome-positive and/or BCR-ABL--positive acute lymphoblastic leukemia-retrospective analysis of Polish Adult Leukemia Group (PALG). Ann Hematol, 85(6), 366-373. doi:10.1007/s00277-006-0099-z

Yokota, T., & Kanakura, Y. (2016). Genetic abnormalities associated with acute lymphoblastic leukemia. Cancer Sci, 107(6), 721-725. doi:10.1111/cas.12927

Zhao, X. S., Liu, Y. R., Zhu, H. H., Xu, L. P., Liu, D. H., Liu, K. Y., & Huang, X. J. (2012). Monitoring MRD with flow cytometry: an effective method to predict relapse for ALL patients after allogeneic hematopoietic stem cell transplantation. Ann Hematol, 91(2), 183-192. doi:10.1007/s00277-011-1285-1